The clinical utility of metagenomic next-generation sequencing in the management of fever in patients with hematological disorders.

Read full text Summarise with VIRAT
Authors: Jiaying Cheng, Jinle Ni, Yu ZHAO, Ling Jiang, Yun Huang, Yujiao Zhang, Ping Yan, Zhiquan Long, Haipeng Fu, Xuejie Jiang
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Patients with hematological malignancies frequently present with severe and intricate infections that pose life-threatening risks. Conventional pathogen detection methods offer limited clinical insights and therapeutic guidance. This retrospective study evaluated the clinical application of metagenomic next-generation sequencing (mNGS) in hematologic patients who remained febrile despite prolonged antibiotic therapy, which means unresponsive to antibiotic therapy. This retrospective analysis included 204 patients with hematologic malignancies, undergoing conventional pathogen detection and peripheral blood mNGS. The cohort was stratified into neutropenia and non-neutropenia groups to compare the diagnostic and therapeutic implications of mNGS versus conventional microbiological tests (CMT). Among the 204 patients with mNGS, the overall positive detection rate was significantly higher than that of CMT (68.1% vs 30.9%, P

Fields of Study & Subjects

Neutropenia and Cancer Infections Bacterial Identification and Susceptibility Testing Neonatal and Maternal Infections

Publication details

Journal / source
PubMed Central
Volume
88
Issue
1
Pages
84–98
Publication date
1 February 2026
Language
EN